Komori
Havix (3895) · RiskMitigated

Delays in New Product Development and New Business Launches

First written in FY2016. 5 of 8 entries say "Restated". Latest entry: FY2026.

8entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2019RestatedFY2021 – FY20222016: 120162017: 120172018: 120182019: 120192020: 120202021: 120212022: 120222023: 020232024: 020242025: 020252026: 12026
Same theme, other companies
New Product Development and Launch Delay RiskA theme 28 companies write about · 28 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2025: 4 of 7 companies on the "Worse" side.

6 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 28 companies compared. The sentences above are computed from all 28.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「The Group is actively pursuing new product development and the development of new businesses. As a new business, it has announced a contract manufacturing arrangement with Unicharm Products Co., Ltd., scheduled to begin in April 2027.」

    Although the risk of delays in launching new businesses continues to be disclosed, the contract manufacturing arrangement and the planned start in April 2027 have become more specific.
  2. FY2022RestatedAnnual report

    「We are moving forward with product development that meets market needs, following detailed schedules and with a strong sense of urgency.」

    To address delays in new product development and new business launches, the Group continues to gather information through customer meetings and trade shows and develop products according to detailed schedules.
  3. FY2021RestatedAnnual report

    「The Group is working to gather information and understand market needs by meeting with business partners and attending exhibitions for new technologies and products. It is also developing products that meet market needs in line with detailed schedules and with a sense of urgency.」

    To address the risk of delays in new product development and new business launches, the Group continues to conduct meetings with business partners, participate in trade shows, identify market needs, and develop products according to detailed schedules.
  4. FY2020MitigatedAnnual report

    「The Group is working to gather information and understand market needs by meeting with business partners and attending exhibitions for new technologies and products. It is also developing products that meet market needs in line with detailed schedules and with a sense of urgency.」

    In response to the risk of delays in new product development and the launch of new businesses, the Group has specified meetings with business partners, participation in exhibitions, understanding market needs and development based on detailed schedules as countermeasures.
  5. FY2019RestatedAnnual report

    「The Group is actively engaged in developing new products and cultivating new businesses. However, if it is unable to launch products that meet market needs, or if the development of new products or the launch of new businesses is delayed, this could reduce the Group's future growth potential and profitability and affect its financial position and operating results.」

    The risk of delays in new product development and the launch of new businesses continues to be disclosed as before.
  6. FY2018RestatedAnnual report

    「The Group is actively engaged in developing new products and cultivating new businesses. However, if it is unable to launch products that meet market needs, or if the development of new products or the launch of new businesses is delayed, this could reduce the Group's future growth potential and profitability and affect its financial position and operating results.」

    The risk of delays in new product development and the launch of new businesses continues to be disclosed as before.
  7. FY2017RestatedAnnual report

    「The Group is actively engaged in developing new products and cultivating new businesses. However, if it is unable to launch products that meet market needs, or if the development of new products or the launch of new businesses is delayed, this could reduce the Group's future growth potential and profitability and affect its financial position and operating results.」

    The risk of delays in new product development and the launch of new businesses continues to be disclosed as before.
  8. FY2016First statedAnnual report

    「The Group is actively engaged in developing new products and cultivating new businesses. However, if it is unable to launch products that meet market needs, or if the development of new products or the launch of new businesses is delayed, this could reduce the Group's future growth potential and profitability and affect its financial position and operating results.」

    This is identified as an execution risk associated with the objectives of cultivating new businesses and conducting research and development.
Moved together

"Expanding sales in the hygiene materials sector" moved the same way as this thread, in the same document, in 2 of its 8 moves.

222★123
  1. ★This thread
  2. 1Expanding sales in the hygiene materials sector2×
  3. 2Exploring New Business Areas, Including the Medical and Nursing Care Sectors2×
  4. 3Advancing the Development of High-Value-Added Products and Applications2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Havix's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.